RAPID + TCT 2024 Executive Perspectives Keynote Series Announced
GlobeNewswire
Featuring industry leaders from across the ecosystem discussing the future of AM
LOS ANGELES, May 16, 2024 (GLOBE..
National Health Authority
News and Video Search Results
News coverage
-
GITEX AFRICA 2024 powers cross continental quest for an Artificial Intelligence (AI) future as region prepares for new digital era
EQS Group
-
Celebrating The Goodness of Walnuts
NewsVoir
-
Aegon appoints Duncan Russell to succeed Matt Rider as Chief Financial Officer
GlobeNewswire
-
Aegon trading update for first quarter 2024
GlobeNewswire
- More about:
Vatican City
0 shares
1 views
You might like
National Health Authority media coverage
AB Science reports its revenues for the year 2023 and provides an update on its activities
GlobeNewswire
*PRESS RELEASE*
*AB SCIENCE PRESENTS ITS FINANCIAL INFORMATION AS OF DECEMBER 31, 2023 AND THE KEY EVENTS..
-
Energy Safety Canada Appoints Former Ovintiv Executive as New President and CEO
GlobeNewswire
-
Newtopia Now Unveils Programming Lineup for August Featuring Dan Buettner, Carla Hall and Top Executives from Ulta, Sprouts, The Vitamin Shoppe and More.
Accesswire
-
Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer's Disease Under the Fast Track Status
ACN Newswire
-
Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Under the Fast Track Status
GlobeNewswire
Advertisement
More coverage
Undisclosed Politics 24x7
Rumble
Watch me break down how the new "Anti-Semitism" Bill has given the government unlimited control. Support the..
-
A Nanny State Idiocracy: A Tale Of Too Many Laws And Too Little Freedom – OpEd
Eurasia Review
-
What Has Vatican Already Said About Discerning Marian Apparitions? – Analysis
Eurasia Review
-
Avicanna Reports Q1 2024 and First Positive Adjusted EBIDTA Quarter
GlobeNewswire
-
Mabwell Announces Clinical Trial Progress of 9MW2821 in Triple-Negative Breast Cancer
PR Newswire Asia